Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tongji Hospital
With
LinkDoc Technology (Beijing) Co. Ltd.
This is a multi-centre real-world non-interventional observational study. The study data on patient demographic/tumor biological characteristics and clinical treatments were retrospectively collected to evaluate effectiveness of sublobar dissection in the Chinese patients with non-small cell lung cancer who received sublobar dissection.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients \>= 18 years old;
Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections);
Patients who received selective or systematic lymphadenectomy;
Pathologically diagnosed patients with non-small cell lung cancer;
Pathological staging: I, II
You may not be if
Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies);
Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;
